New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

Researchers have discovered a new type of neuron that plays a fundamental role in recognition memory -- how the brain registers the difference between new and familiar objects and forms long-term ...

Doug Whitney, a 75-yearold Navy veteran from Washington State, lost 10 members of his family to early-onset Alzheimer's ...

US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...

It is based on initial research led by Dr Maura Malpetti, who received the Race Against Dementia Fellowship in 2021 from the ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

Researchers at Washington University School of Medicine in St. Louis have devised a way to communicate the effects of taking the new Alzheimer’s medications in language that is accessible and ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...